235 related articles for article (PubMed ID: 8693967)
1. [Recurrent and up-grading bladder cancer in a young female: a case report].
Ouchi H; Noguchi S; Masuda M; Yao M; Kubota Y; Hosaka M
Hinyokika Kiyo; 1996 Apr; 42(4):311-3. PubMed ID: 8693967
[TBL] [Abstract][Full Text] [Related]
2. [Only metastasis to uterine corpus from superficial bladder cancer that of no original recurrence].
Murakami T; Hoshino K; Hasumi H; Makiyama K; Miyoshi Y; Yoshida M; Nakaigawa N; Ogawa T; Uemura H; Yao M; Kubota Y
Hinyokika Kiyo; 2007 Jan; 53(1):75-7. PubMed ID: 17310775
[TBL] [Abstract][Full Text] [Related]
3. [A case of transitional cell carcinoma with squamous differentiation which developed squamous cell carcinoma in situ in the clinical course].
Sugiura S; Makiyama K; Yokomizo Y; Umemoto S; Miyoshi Y; Nakaigawa N; Ogawa T; Uemurai H; Yao M; Kubota Y; Yamanaka S
Hinyokika Kiyo; 2006 Sep; 52(9):715-8. PubMed ID: 17040058
[TBL] [Abstract][Full Text] [Related]
4. [Recurrent transitional cell carcinoma of the bladder in a young woman: report of a case].
Ikeda I; Terao T; Nakagomi K; Masuda M; Hirokawa M
Hinyokika Kiyo; 1992 Nov; 38(11):1261-3. PubMed ID: 1485578
[TBL] [Abstract][Full Text] [Related]
5. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
[TBL] [Abstract][Full Text] [Related]
6. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
[TBL] [Abstract][Full Text] [Related]
7. [A case of CEA and CA19-9 producing recurrent transitional cell carcinoma in an Indiana pouch after total cystectomy].
Miyoshi Y; Asakura T; Matsuzaki J; Fukuda M; Satomi Y; Akabane H
Hinyokika Kiyo; 1996 Dec; 42(12):961-4. PubMed ID: 9013232
[TBL] [Abstract][Full Text] [Related]
8. [A clinical study of recurrence and progression of grade 3 superficial bladder tumor].
Ikegami S; Tsuji A; Suzuki S; Sumitomo M; Kimura F; Asano T; Nakajima F; Hayakawa M
Hinyokika Kiyo; 1999 May; 45(5):325-9. PubMed ID: 10410314
[TBL] [Abstract][Full Text] [Related]
9. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
10. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
[TBL] [Abstract][Full Text] [Related]
11. Management of panurothelial disease in superficial bladder cancer.
Srougi M; Antunes AA; Dall'Oglio MF; Cury J
Nat Clin Pract Urol; 2006 May; 3(5):284-8. PubMed ID: 16691242
[TBL] [Abstract][Full Text] [Related]
12. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
13. Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin.
Brake M; Loertzer H; Horsch R; Keller H
J Urol; 2000 Jun; 163(6):1697-701. PubMed ID: 10799163
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
15. [Case report: a case with small cell carcinoma of the bladder transformed from urothelial carcinoma].
Okuda H; Tei N; Nakamura Y; Shimizu K; Yoshimura K; Kiyohara H
Hinyokika Kiyo; 2008 Apr; 54(4):285-7. PubMed ID: 18516922
[TBL] [Abstract][Full Text] [Related]
16. Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer.
Cheng CW; Chan SF; Chan LW; Chan CK; Ng CF; Cheung HY; Chan SY; Wong WS; Lai FM; To KF; Li ML
Int J Urol; 2005 May; 12(5):449-55. PubMed ID: 15948743
[TBL] [Abstract][Full Text] [Related]
17. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis.
Uchida A; Yonou H; Hayashi E; Iha K; Oda M; Miyazato M; Oshiro Y; Hokama S; Sugaya K; Ogawa Y
Urology; 2007 Feb; 69(2):275-9. PubMed ID: 17320663
[TBL] [Abstract][Full Text] [Related]
18. TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years.
Serretta V; Pavone C; Ingargiola GB; Daricello G; Allegro R; Pavone-Macaluso M
Eur Urol; 2004 Jun; 45(6):730-5; discussion 735-6. PubMed ID: 15149744
[TBL] [Abstract][Full Text] [Related]
19. [Changes in grading at bladder tumor recurrence].
Uchida T; Kobayashi K; Arakawa T; Omata T; Endo T; Ishibashi A; Koshiba K
Hinyokika Kiyo; 1984 Dec; 30(12):1785-91. PubMed ID: 6532206
[TBL] [Abstract][Full Text] [Related]
20. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
